Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;50(12):1571-1574.
doi: 10.1111/imj.15113.

Specificity of serum amyloid A as a biomarker of idiopathic pulmonary fibrosis

Lucia Vietri #  1 , Miriana d'Alessandro #  1 , Laura Bergantini  1 , Alfonso Carleo  1 , Paolo Cameli  1 , Maria Antonietta Mazzei  2 , Piersante Sestini  1 , Elena Bargagli  1
Affiliations

Specificity of serum amyloid A as a biomarker of idiopathic pulmonary fibrosis

Lucia Vietri et al. Intern Med J. 2020 Dec.

Abstract

Serum amyloid A (SAA) is an apo-lipoprotein produced by the liver in response to proinflammatory cytokines. Few data are available on SAA levels in patients with idiopathic pulmonary fibrosis (IPF), the most common idiopathic form of interstitial pneumonitis (ILD). This study compared SAA concentration in IPF patients to other ILD groups to explore its potential use as a clinical biomarker.

Keywords: chronic hypersensitivity pneumonitis; idiopathic pulmonary fibrosis; pulmonary Langerhans cell histiocytosis; sarcoidosis; serum amyloid A.

PubMed Disclaimer

Comment in

  • Author reply.
    d'Alessandro M, Vietri L, Bergantini L, Bargagli E. d'Alessandro M, et al. Intern Med J. 2021 Jul;51(7):1197. doi: 10.1111/imj.15406. Intern Med J. 2021. PMID: 34278697 No abstract available.
  • Serum amyloid A as a universal biomarker in lung disease.
    O'Reilly S. O'Reilly S. Intern Med J. 2021 Jul;51(7):1195-1196. doi: 10.1111/imj.15324. Intern Med J. 2021. PMID: 34278698 No abstract available.

References

    1. De Buck M, Gouwy M, Wang JM, Van Snick J, Opdenakker G, Struyf S et al. Structure and expression of different serum amyloid A (SAA) variants and their concentration-dependent functions during host insults. Curr Med Chem 2016; 23: 1725-55.
    1. Sack GH Jr. Serum amyloid A - a review. Mol Med 2018; 24: 46.
    1. Jayaraman S, Haupt C, Gursky O. Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA. J Lipid Res 2016; 57: 2138-49.
    1. Bozinovski S, Vlahos R, Anthony D, McQualter J, Anderson G, Irving L et al. COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link. Br J Pharmacol 2016; 173: 635-48.
    1. Vietri L, Fui A, Bergantini L, d'Alessandro M, Cameli P, Sestini P et al. Serum amyloid A: a potential biomarker of lung disorders. Respir Investig 2020; 58: 21-7.

LinkOut - more resources